This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
24 Jan 2017 | Asia Pacific | Market Research
Game-changing Strategies of APAC Pharma Companies
Growing Focus on Specific Therapy Areas and Shift Towards Value-based Delivery Model Expected to Boost Pharma Market
Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...
$1,500.00 -
14 Nov 2016 | Asia Pacific | Market Research
Analysis of the Indonesian Clinical Laboratories Market
Increase in Test Volumes Due to Universal Health Coverage will Boost Market Growth Across All Segments
Given the ever-increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from health settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinic laboratory diagnostics. Effective delivery of healthcare services has created a business and technology convergence be...
$1,500.00 -
11 Nov 2016 | Asia Pacific | Market Research
Analysis of the Australian Clinical Laboratory Market
Evolving Business Model—Technological Advances will Drive the Market
Given the ever increasing cost of care, healthcare delivery is moving towards decentralisation. Service delivery from healthcare settings such as mobile clinics, rapid retail clinics, and home settings demands the use of new-age clinical laboratory diagnostics. The effective delivery of healthcare services has created a business and technology conv...
$1,500.00 -
12 Jul 2016 | Asia Pacific | Market Research
Analysis of the APAC Health Information Exchange Market
This research service analyzes the health information exchange (HIE) market in Asia-Pacific. Driven primarily by governments, the region is embarking on the next phase of healthcare IT transformation, investing in decentralizing patient information by enabling data exchange among established electronic medical record (EMR) and electronic health rec...
$4,950.00 -
31 May 2016 | Asia Pacific | Market Research
2016 Indonesia Transformational Health Insights
Current Trends and Challenges Encountered in the Road to Achieving Universal Healthcare Coverage
Indonesia is expected to see a substantial rise in healthcare spending driven by rapid urbanization, a growing middle class population, and an increasing prevalence of chronic diseases. Government initiatives to provide universal healthcare coverage (UHC) by 2019 are one of the key reasons for making Indonesia an attractive healthcare market. All t...
$1,500.00 -
06 May 2016 | Asia Pacific | Market Research
Global Generic Pharmaceuticals Market, Forecast to 2020
Market Participants Target High Value-added Branded Generics and Biosimilars Segments
The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....
$4,950.00 -
22 Apr 2016 | Asia Pacific | Market Research
ASEAN Pharmaceutical Regulatory Landscape
ASEAN Economic Community (AEC) to Push Free Flow of Goods, Services and Investments, Creating $160 Billion Opportunity
This study aims is to analyse the ASEAN pharmaceutical regulatory landscape in terms of the ease of doing business, the impact of harmonisation post AEC 2015, and the key factors and dynamics influencing member countries and the outside world. It also provides strategic recommendations for market participants and conclusions. An overview of the reg...
$3,000.00 -
15 Dec 2015 | Asia Pacific | Market Research
Analysis of the Medical Imaging Market in Selected ASEAN Countries
Growth and Trends in CT, MR, PET, and SPECT Modalities
This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...
$6,000.00 -
08 Dec 2015 | Asia Pacific | Market Research
A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth
The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...
$6,000.00 -
11 Nov 2015 | Asia Pacific | Market Research
Asia-Pacific Point-of-Care Testing Market
Trends, Challenges, and Best Practices for Stakeholders
Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...
$4,950.00
